This is how he answered the agency’s question about which vaccines being developed at the center can be expected in 2022.
“First of all, the nasal vaccine should become available,” Ginzburg said.
At the end of the year, according to him, it is planned to conduct clinical trials of a preventive drug that protects immediately from influenza and coronavirus.
“I think that next year the vaccine will be available to all children — those who wish, of course – vaccination will be absolutely voluntary. And this is very important,” Ginzburg said.
Now in Several COVID-19 vaccines developed at the Gamalea Center have been registered in Russia. In August 2020, a registration certificate was issued for the drug “Sputnik V”.
In May 2021, it became known about the registration of the Sputnik Lite vaccine, and in November, the Sputnik M vaccine for adolescents was approved.